Microvascular disease, statins, ACE-inhibitors and post-operative SBO

微血管疾病、他汀类药物、ACE 抑制剂和术后 SBO

基本信息

  • 批准号:
    8534778
  • 负责人:
  • 金额:
    $ 15.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is an application for a K08 award for Dr. Frank I. Scott, who will be an Instructor at the University of Pennsylvania starting July 1, 2011. This K08 will provide the candidate with the necessary support to launch a successful career in epidemiologic research in post-operative adhesion-related complications. To achieve his goals, Dr. Scott has proposed a comprehensive career development plan: (1) to implement advanced epidemiologic and biostatistical methods to conduct observational research~ (2) to develop a new research tool for the study of complications of abdominal surgery and post-surgical small bowel obstruction (SBO)~ (3) to conduct research on host-related risk factors and modifiers of adhesion-related SBO~ and (4) to develop an independent research career in epidemiologic and clinical research. Dr. Scott has assembled a mentoring team to assist him in achieving these goals. Dr. James D. Lewis, MD, MSCE, Professor of Medicine and Epidemiology in the Division of Gastroenterology at the University of Pennsylvania, will serve as the candidate's primary mentor. Dr. Lewis is a world-renowned expert in pharmacoepidemiology and gastrointestinal disease epidemiology. Dr. Gary D. Wu, MD, Professor of Medicine and Associate Chief of Research in the Gastroenterology Division will serve as an advisor. Dr. Najjia N. Mahmoud, MD, Associate Professor of Surgery, who has collaborated with Dr. Scott and Dr. Lewis on prior adhesion-related research, will continue to provide invaluable input as an advisor. Dr. Wensheng Guo, PhD, in the department of Biostatistics and Epidemiology, will share his expertise in longitudinal analyses. Post-operative adhesions are responsible for a significant amount of morbidity and mortality, and are the leading cause of SBO in adults. Little is currently known about which host-related factors may impact the risk of post-operative SBO, although hypoxia appears to play a role in animal models. Dr. Scott's research will examine the impact of co-morbid medical conditions associated with microvascular disease on the incidence of post-operative SBO utilizing data from The Health Improvement Network (THIN). Prior research efforts have been limited by the lack of valid medical data from a large population undergoing abdominal surgery. The proposed research will validate diagnostic codes for abdominal surgery and SBO within THIN, thereby generating a novel dataset for such research (AIM 1). The candidate will then conduct a case-control study to assess the association between several common medical conditions, such as hypertension, hyperlipidemia, and diabetes, with the risk of SBO after an intra-abdominal surgery using THIN (AIM 2). Finally, he will assess the effects of statins and ACE-inhibitors, which have known pleiotropic anti-fibrotic effects, on the incidence of post-operative SBO (AIM 3). This research will serve as the foundation for future prospective evaluation of the effect of risk factor modification and medication use to prevent adhesion-related SBO.
描述(由申请人提供):这是弗兰克·斯科特(Frank I. 将为候选人提供必要的支持,以启动与术后相关并发症的流行病学研究成功事业。 为了实现自己的目标,斯科特博士提出了一项全面的职业发展计划:(1)实施先进的流行病学和生物统计学方法,以开发观察性研究〜(2)开发一种新的研究工具,以研究腹部手术并发症的研究,并进行手术后的小肠阻塞(SBO)〜(SBO)〜(SBO)〜(SBO)〜(3),以对宿主的风险和模态攻击量(4)进行研究(4在流行病学和临床研究中。 斯科特博士已经组建了一个指导团队,以协助他实现这些目标。 MSCE医学博士James D. Lewis博士,宾夕法尼亚大学胃肠病学系医学和流行病学教授,将担任候选人的主要导师。 刘易斯博士是一位世界知名的药物ePidemiology和胃肠道疾病流行病学专家。 医学博士Gary D. Wu博士,医学教授兼胃肠病学副研究主任将担任顾问。 外科副教授Najjia N. Mahmoud博士与Scott博士和Lewis博士合作进行了与粘附相关的研究,他将继续作为顾问提供宝贵的意见。 生物统计学和流行病学系的Wensheng Guo博士将在纵向分析中分享他的专业知识。 术后粘连是为了 大量的发病率和死亡率是成年人SBO的主要原因。尽管缺氧似乎在动物模型中起作用,但目前对哪些与宿主相关的因素可能影响术后SBO的风险鲜为人知。 Scott博士的研究将检查与微血管疾病相关的合并医疗状况对使用健康改善网络(THIN)数据的术后SBO发生率的影响。 因缺乏大量腹部手术人群的有效医疗数据而受到限制。拟议的研究将验证腹部手术和SBO的诊断代码,从而生成一个新的数据集(AIM 1)。 然后,候选人将进行一项病例对照研究,以评估几种常见的医疗状况(例如高血压,高脂血症和糖尿病)之间的关联,并使用薄薄的腹腔内手术后的SBO风险(AIM 2)。 最后,他将评估他汀类药物和ACE抑制剂的影响,这些抑制剂已知多效性抗纤维化作用对术后SBO的发生率(AIM 3)。这项研究将成为对危险因素修饰和药物使用的影响的未来预期评估,以防止与粘附相关的SBO。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Frank Irving Scott其他文献

Frank Irving Scott的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Frank Irving Scott', 18)}}的其他基金

Microvascular disease, statins, ACE-inhibitors and post-operative SBO
微血管疾病、他汀类药物、ACE 抑制剂和术后 SBO
  • 批准号:
    8695341
  • 财政年份:
    2012
  • 资助金额:
    $ 15.46万
  • 项目类别:
Microvascular disease, statins, ACE-inhibitors and post-operative SBO
微血管疾病、他汀类药物、ACE 抑制剂和术后 SBO
  • 批准号:
    8353125
  • 财政年份:
    2012
  • 资助金额:
    $ 15.46万
  • 项目类别:
Microvascular disease, statins, ACE-inhibitors and post-operative SBO
微血管疾病、他汀类药物、ACE 抑制剂和术后 SBO
  • 批准号:
    8898785
  • 财政年份:
    2012
  • 资助金额:
    $ 15.46万
  • 项目类别:

相似国自然基金

高毒力肺炎克雷伯菌T6SS效应蛋白Hcp诱导内皮细胞焦亡促发肝脓肿相关免疫血栓的机制研究
  • 批准号:
    82302325
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
脓肿分枝杆菌耐药基因的进化机制研究
  • 批准号:
    32300507
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Irp2缺失引起肝脏免疫功能损伤造成肝脓肿的机制研究
  • 批准号:
    32271221
  • 批准年份:
    2022
  • 资助金额:
    54.00 万元
  • 项目类别:
    面上项目
高糖条件下中性粒细胞NETs激活内皮细胞促发侵袭性肺炎克雷伯菌肝脓肿综合征的机制研究
  • 批准号:
    82272097
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
Irp2缺失引起肝脏免疫功能损伤造成肝脓肿的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目

相似海外基金

Improving the safety and effectiveness of adhesion prevention following colorectal procedures with high risk of cancer or infection
提高癌症或感染高风险结直肠手术后预防粘连的安全性和有效性
  • 批准号:
    10603903
  • 财政年份:
    2022
  • 资助金额:
    $ 15.46万
  • 项目类别:
A rapid, automated system for bacteria profiling of intra-abdominal infections
一种快速、自动化的腹内感染细菌分析系统
  • 批准号:
    10535472
  • 财政年份:
    2021
  • 资助金额:
    $ 15.46万
  • 项目类别:
Therapeutic Antibodies for Treating Inflammatory Bowel Disease
用于治疗炎症性肠病的治疗性抗体
  • 批准号:
    10255435
  • 财政年份:
    2021
  • 资助金额:
    $ 15.46万
  • 项目类别:
A rapid, automated system for bacteria profiling of intra-abdominal infections
一种快速、自动化的腹内感染细菌分析系统
  • 批准号:
    10211909
  • 财政年份:
    2021
  • 资助金额:
    $ 15.46万
  • 项目类别:
LASER TISSUE WELDING: BREACHING BARRIERS IN THE SURGICAL MANAGEMENT OF THE PANCREAS
激光组织焊接:突破胰腺手术治疗的障碍
  • 批准号:
    9263921
  • 财政年份:
    2016
  • 资助金额:
    $ 15.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了